Ken Griffin Galecto, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Galecto, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 30,600 shares of GLTO stock, worth $18,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,600
Previous 2,300
1230.43%
Holding current value
$18,666
Previous $1,000
2200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GLTO
# of Institutions
28Shares Held
3.96MCall Options Held
30.6KPut Options Held
200-
Novo Holdings Hellerup, G72.5MShares$1.52 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny579KShares$353,1790.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA221KShares$134,9320.0% of portfolio
-
Geode Capital Management, LLC Boston, MA208KShares$127,0830.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX73.1KShares$44,5910.0% of portfolio
About Galecto, Inc.
- Ticker GLTO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,395,700
- Market Cap $15.5M
- Description
- Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...